Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis.
Mirjam
M
Beyerler
Peter
P
Schmid-Grendelmeier
Jürg
J
Hafner
D000287:Administration, Topical; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000378:metabolism; D004338:Drug Combinations; D005260:Female; D005780:Gelatin / Q000008:administration & dosage; D005990:Glycerol / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008875:Middle Aged; D009779:Occlusive Dressings; D009824:Ointments; D016559:Tacrolimus / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D017967:Zinc Compounds / Q000008:administration & dosage
D004338:Drug Combinations; D007166:Immunosuppressive Agents; D009824:Ointments; D017967:Zinc Compounds; C009622:gelatin, glycerin, zinc oxide drug combination; D005780:Gelatin; D005990:Glycerol; D016559:Tacrolimus